Ladies and Gentlemen,
Partners, Colleagues, and Valued Stakeholders,

Abhishek Kumar Singh, CEO of Taj Pharma Group
Abhishek Kumar Singh, CEO of Taj Pharma

It gives me immense pride to address you on behalf of Taj Pharma India Ltd., a company founded on the principles of excellence, innovation, and responsibility in pharmaceutical manufacturing. With our state-of-the-art manufacturing facility located in Sarigam, Gujarat, strategically within the GIDC zone, Taj Pharma stands today as a beacon of quality, integrity, and global competitiveness.

Our Sarigam OSD and External Preparations Plant is the heart of our operations—designed with precision to deliver superior output across a wide spectrum of dosage forms. From Oral solids, Oral Powder, effervescent tablets, creams, ointments, jellies, and sachets, our monthly capacity spans over 120 million tablets, 40 million capsules, 60 million jellies, and more—underscoring our scalable and flexible production strength.

We are proud to operate in full compliance with WHO-GMP, ISO 9001:2018, PIC/S, and in pursuit of EU-GMP certification—ensuring that every product meets the strictest global standards. At the core of our manufacturing excellence lies our robust Quality Assurance framework, which governs every facet of our operations—from SOPs, process validation, and documentation, to batch release and data integrity.

Our Warehouse and Material Dispensing Department is built on best-in-class infrastructure, equipped with zoned storage, air-conditioned units, RLAF booths, barcoding, and Pharma ERP integration, ensuring precise, traceable, and compliant handling of all raw and packaging materials. This precision extends to our Engineering, R&D, and Regulatory Affairs teams, who contribute to seamless technology transfers, formulation development, and real-time regulatory alignment.

Taj Pharma’s digital backbone—through validated systems like LIMS, SCADA, and cloud-based ERP—empowers us to maintain ALCOA+ data integrity standards, and real-time operational control, fulfilling expectations of regulators, clients, and patients alike.

We are not merely manufacturers; we are partners in global healthcare advancement. With contract manufacturing (CMO/CDMO) offerings, we provide end-to-end services including formulation optimization, stability studies, regulatory dossier support (CTD/ACTD), and serialization-ready packaging, empowering our partners to focus on growth while we deliver quality, compliance, and speed.

As we step into the future, Taj Pharma remains committed to sustainability, quality innovation, and global accessibility. Our workforce, our values, and our infrastructure reflect one unified purpose—to make high-quality, affordable medicines available to every patient in need, across geographies.

Let us continue to uphold the trust placed in us by millions. Let us lead with science, act with integrity, and serve with purpose.

Thank you for being an integral part of our journey.

Warm regards,

Mr.Abhishek Singh
CEO – Taj Pharma